Recent Updates
Recently added Catalysts
HELP Positive Sentiment

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Wednesday, September 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Helus Pharma is set to participate in the H.C. Wainwright 28th Annual Global Investment Conference in New York. CEO Michael Halstead will engage in a fireside chat on September 14, 2026, at 9:00 a.m. EDT. This event presents an opportunity for the company to connect with investors and showcase its clinical-stage developments.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant investment conference
  • Opportunity for CEO to engage with investors
  • Increased visibility for Helus Pharma

Full Press Release Details

CEO Michael Halstead to participate in a fireside chat on Monday, September 14, 2026 at 9:00 a.m. EDT NEW YORK and TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping

Frequently Asked Questions

When is Helus Pharma's participation in the conference?

Helus Pharma will participate in the conference on September 14, 2026.

Who will represent Helus Pharma at the conference?

CEO Michael Halstead will represent Helus Pharma at the conference.

What time is the fireside chat scheduled?

The fireside chat is scheduled for 9:00 a.m. EDT.

Where is the H.C. Wainwright conference taking place?

The conference is taking place in New York.

ShareAdd on Google
Tags: HELP Viatris Investor Conferences Healthcare Helus Pharma H.C. Wainwright investment conference CEO Michael Halstead clinical-stage
Last updated: Sep 9, 2026

Biotech snapshot

Lead asset
CYB003Phase 3
Major Depressive Disorder →